Document:

<PAGE>
                                                                     Exhibit 4.2

                             SECURED PROMISSORY NOTE

     The undersigned corporations, namely, Americare Health Scan, Inc. and its
subsidiary Americare Biologicals, Inc. (hereinafter referred to as "Borrower"),
whose address is 20 NW 181st Street, Miami, Florida 33169, promises to pay
DAYCON INVESTORS ASSOCIATES, INC.,(hereinafter Daycon) whose address is 20 NW
181st Street, Miami, Florida 33169, the principal sum of One Million Dollars
($1,000,000.00). That said funds are due and owing to Daycon for monies advanced
to Borrower and for Daycon's willingness to advance additional funds and
Borrower's willingness and need to continue to receive additional funds and
consideration of said funding by Daycon to Borrower and forebearance on
initiating collection or demand on the previously advanced funds to Borrower,
Borrower hereby agrees to execute this blanket promissory note and additionally
agrees to execute a security agreement collateralizing Borrower's assets as
specifically set forth in the Security Agreement and/or financing statement.
Further, Borrower authorizes Daycon to execute the financing statement and take
a real estate mortgage on property of Borrower at Daycon's sole discretion. That
this instrument is given by Borrower without relief from Valuation, Stay or
Appraisement Laws and along with attorneys fees and costs of collection in the
case of default.

     This Note shall bear interest at two (2%) percent over the prime rate of
interest as set from time to time by Chase Manhattan Bank of New York, however,
in no event shall the rate of interest be less than eight (8%) percent per annum
compounded monthly, nor more than eighteen (18%) percent.

     This Note shall become fully due and payable on demand, but in no event
earlier than sixty (60) days from the execution hereof, unless there shall be a
default under any of the terms and conditions of this Note and correlative
Security Agreement or Financing Statement.

     Upon default in the payment of any installment or other payment herein
required when the same shall become due, or in the event the holder deems itself
insecure, the entire unpaid balance and other indebtedness on account of this
obligation and mortgage, term loan agreement and security agreement securing the
same shall, at the option of the holder, become due and payable immediately
without notice of non-payment or demand for payment, and the entire indebtedness
may be collected by appropriate proceedings, together with interest at the rate
of two (2%) percent in excess of the rate hereinabove stated, computed from the
time of default on each delinquent installment until paid, or on the entire
unpaid principal balance at the option of the holder, if maturity of the entire
indebtedness is accelerated. No failure on the part of the holder in exercising
said option to declare the whole of said indebtedness due or to proceed to
collect the same shall operate as a waiver of the right to do so or preclude the
exercise of such option at any time during the continuance of such default or
the occurrence of a succeeding default. Advance payment may be made in any
amount, and interest on such advance payments shall not be charged beyond the
next succeeding interest period.<PAGE>
                                                                     Exhibit 4.3

                             SECURED PROMISSORY NOTE

     The undersigned corporations, namely, Americare Health Scan, Inc. and its
subsidiary Americare Biologicals, Inc. (hereinafter referred to as "Borrower"),
whose address is 20 NW 181st Street, Miami, Florida 33169, promises to pay
AMERICARE SERVICES, INC., (hereinafter Americare) whose address is 20 NW 181st
Street, Miami, Florida 33169, the principal sum of Two Hundred Thousand Dollars
($200,000.00). That said funds are due and owing to Americare for monies
advanced to Borrower and for Americare's willingness to advance additional funds
and Borrower's willingness and need to continue to receive additional funds and
consideration of said funding by Americare to Borrower and forebearance on
initiating collection or demand on the previously advanced funds to Borrower,
Borrower hereby agrees to execute this blanket promissory note and additionally
agrees to execute a security agreement collateralizing Borrower's assets as
specifically set forth in the Security Agreement and /or financing statement.
Further, Borrower authorizes Americare to execute the financing statement and
take a real estate mortgage on property of Borrower at Americare's sole
discretion. That this instrument is given by Borrower without relief from
Valuation, Stay or Appraisement Laws and along with attorneys fees and costs of
collection in the case of default.

     This Note shall bear interest at two (2%) percent over the prime rate of
interest as set from time to time by Chase Manhattan Bank of New York, however,
in no event shall the rate of interest be less than eight (8%) percent per annum
compounded monthly, nor more than eighteen (18%) percent.

     This Note shall become fully due and payable on demand, but in no event
earlier than sixty (60) days from the execution hereof, unless there shall be a
default under any of the terms and conditions of this Note and correlative
Security Agreement or Financing Statement.

       Upon default in the payment of any installment or other payment herein
required when the same shall become due, or in the event the holder deems itself
insecure, the entire unpaid balance and other indebtedness on account of this
obligation and mortgage, term loan agreement and security agreement securing the
same shall, at the option of the holder, become due and payable immediately
without notice of non-payment or demand for payment, and the entire indebtedness
may be collected by appropriate proceedings, together with interest at the rate
of two (2%) percent in excess of the rate hereinabove stated, computed from the
time of default on each delinquent installment until paid, or on the entire
unpaid principal balance at the option of the holder, if maturity of the entire
indebtedness is accelerated. No failure on the part of the holder in exercising
said option to declare the whole of said indebtedness due or to proceed to
collect the same shall operate as a waiver of the right to do so or preclude the
exercise of such option at any time during the continuance of such default or
the occurrence of a succeeding default. Advance payment may be made in any
amount, and interest on such advance payments shall not be charged beyond the
next succeeding interest period.

<PAGE>

     The holder may renew the same or extend time of payment of the indebtedness
or any part thereof or reduce the payments thereon; and any such renewal,
extension or reduction shall not release any maker, endorser or guarantor from
any liability on said obligation. This note is subject to the terms and
conditions of a certain contract and Security Agreement (of even date herewith)
entered into by and between the promissor and the payee, said agreements being
incorporated herein by reference, with the same force and effect as though fully
set forth herein.

     The drawers, sureties, guarantors and endorsers severally waive presentment
for payment, protest, notice of protest and non-payment of this note. The
receipt of interest in advance or the extension of time shall not release or
discharge any surety, guarantor or endorser on this note.

                                       Americare Health Scan, Inc.

                                       By: /s/ Joseph P. D'Angelo
                                           -------------------------------------
                                           President

                                       Attest: /s/ Margaret Heichberger
                                               ---------------------------------
                                               Secretary

                                       Americare Biologicals, Inc.

                                       By: /s/ Joseph P. D'Angelo
                                           -------------------------------------
                                           President

                                       Attest: /s/ Margaret Heichberger
                                               ---------------------------------
                                               Secretary

Duly Executed this 11th day of May, 2000.

                                       2<PAGE>
                                                                    Exhibit 10.1

                                   ASSIGNMENT

Whereas Americare Biologicals, Inc., a Florida company located and doing
business at Miami, Florida, has adopted and used in its business the following
trademark filed in the United States Patent and Trademark Office:

Serial  No.                         Mark             Filed
-----------                         ----             -----

75/106,456                          ANA-SAL      May 20, 1996

and whereas Americare Health Scan, Inc. and Americare International Diagnostics,
Inc., Florida corporations located and doing business at Miami, Florida, are
desirous of acquiring said mark:

NOW, THEREFORE, in consideration of a duly executed contract between said three
corporations and other good and valuable consideration, the receipt of which is
hereby acknowledged, said Americare Biologicals, Inc., does sell, assign,
transfer, and set over unto said Americare Health Scan, Inc. and Americare
International Diagnostics, Inc., the entire right, title, and interest in, to
and under said trademark application and that part of the goodwill of the
business connected with the use of and symbolized by the mark.

                                       By: /s/ Joseph P. D'Angelo
                                           -------------------------------------
                                           Joseph P. D'Angelo

Date: 16 June 97

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00031-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00031-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00031-of-00352.parquet"}]]